Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: services pharmaco risk cfm
Navigating market access pathways across European Union markets in 2025 and beyond What do the joint clinical assessments (JCA) in Europe mean for your pharma or medtech company? The parallel paths of the joint clinical assessment process and the …
… doi: 10.1182/blood-2019-122841. Related Services Health Economics: Database Studies Staff Members …
… https://doi.org/10.1007/s10549-022-06845-4 . Related Services Health Economics Staff Members Ravi Goyal …
… To reflect future Centers for Medicare & Medicaid Services price negotiation under the Inflation Reduction Act, … loss of exclusivity or Centers for Medicare & Medicaid Services negotiation is expected among all active comparators … critical review of evaluations from 2018 to 2019. Related Services Health Economics Staff Members Naoko Ronquest Kyle …
Joint Clinical Assessment Support Get Ready for Your 100-Day Sprint With only 100 days between confirmation of the Population, Intervention, Comparator(s) and Outcomes (PICOs) and dossier submission, companies getting prepared now will be in the best …
… “Terms”). Vendor’s delivery of products, performance of services, or issuance of invoices in connection with this …
… Related Services Patient-Centered Outcomes Assessment Staff Members …
Therapeutic Experience Explore our Projects, Publications, and Researchers by Therapeutic Area To help you achieve your goal of treating and making your patients healthier, your research partner needs to have both functional expertise and therapeutic …
RTI International Earns 2022 Military Friendly® Employer Designation Share on: November 11, 2021 The institute also earned a high ranking on the Military Friendly® Supplier Diversity Program list RTI International—a nonprofit research institute …
A Cost-Effectiveness Analysis Using Real-World Data William Herring, PhD Director, Health Economics RTI Health Solutions A Cost-Effectiveness Analysis Using Real-World Data from the MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with …